SCHEMBL9954050

SCHEMBL9954050

COCCNN(C#N)c1nc2ccc(Br)cc2c(=O)n1CCOC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 4/20 0.41
ALDH1A1 P00352 8/20 0.37
CYP1A2 P05177 4/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
CYP2D6 P10635 3/20 0.36
CASP1 P29466 3/20 0.36
CASP7 P55210 3/20 0.36
CYP3A4 P08684 3/20 0.36
TSHR P16473 2/20 0.36
USP2 O75604 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
GLA P06280 2/20 0.36
KDM4E B2RXH2 1/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
CASP3 P42574 1/20 0.35
CYP2C9 P11712 2/20 0.35
ALOX15 P16050 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9954169 0.76 FLT3 (0.42) HSD17B10ALDH1A1MEN1KMT2ACASP1
SCHEMBL9953325 0.74 HSD17B10 (0.49) HSD17B10ALDH1A1CYP1A2MEN1KMT2A
SCHEMBL10289053 0.73 KDM4E (0.50) HSD17B10ALDH1A1CYP1A2MEN1KMT2A
SCHEMBL9954047 0.73 HSD17B10 (0.41) HSD17B10ALDH1A1CYP1A2MEN1KMT2A
SCHEMBL9955265 0.72 HSD17B10 (0.41) HSD17B10ALDH1A1CYP1A2MEN1KMT2A
SCHEMBL31241102 0.65 CACNA2D1 (0.42) ALDH1A1MEN1KMT2AUSP2KDM4E
SCHEMBL192788 0.62 TP53 (0.51) ALDH1A1USP2CASP3LMNACACNA2D1
SCHEMBL24381882 0.62 ATM (0.57)
SCHEMBL31416011 0.62 CACNA2D1 (0.41) ALDH1A1KDM4ECASP3LMNACACNA2D1
SCHEMBL27074573 0.62 CACNA2D1 (0.41) ALDH1A1KDM4ECASP3LMNACACNA2D1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012087938-A1 QUINAZOLINONE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-06-28 WO disclosed